New MS Drug, Plasma Therapy for COVID, Ovarian Cancer and Pregnancy, Video Game Treatment for Cognitive Function, and More

Kesimpta (Ofatumumab) depletes a type of immune B cells believed to cause nervous system damage.

HEALTH NEWS ROUNDUP View Online

Top News Stories NEUROLOGY Monthly Self-Injection Approved for Relapsing Forms of MS Kesimpta (Ofatumumab) depletes a type of immune B cells believed to cause nervous system damage. By Brian P. Dunleavy | August 24, 2020 READ MORE

INFECTIOUS DISEASES What We Do and Don't Know About Convalescent Plasma as a COVID-19 Treatment Hospitalized patients with severe illness will have more access to this experimental therapy. By Becky Upham | August 26, 2020 READ MORE

CANCER Get the Latest Info on Ovarian Cancer and Pregnancy It's important to know your ovarian cancer risk when family planning and how a prior diagnosis can affect fertility. By Liz Scherer | August 27, 2020 READ MORE

NEUROLOGY Video Game Treatment May Improve Cognitive Function New research indicates that a novel, video-game-style intervention may be beneficial. By Trevis Gleason | August 25, 2020 READ MORE

INFECTIOUS DISEASES Legionnaires' Disease Risk Grows as Lockdowns Lift Experts warn that Legionella bacteria may pose a danger as workers return to offices and children go back to school. By Don Rauf | August 27, 2020 READ MORE

See All Of Our Great Newsletter Options! SIGN UP TODAY

You are receiving this email because you are signed up to receive emails from Everyday Health. You are registered with techandgio.cpex@blogger.com. Remove me from this list | Add me to this list | Manage my email settings | Customer Service Copyright © 2020 Everyday Health, Inc. All rights reserved. 345 Hudson Street, 16th Floor, New York, NY 10014 Subject to our terms of service and privacy policy